Kite's ZUMA-2 Cohort 3 trial in BTKi-naive mantle cell lymphoma completes, results postedAug 18Trial updatebrexucabtagene autoleucelFludarabine
Nkarta reports Q2 2026 results, continued enrollment in autoimmune NK-cell trialsAug 10Quarterly updateNkarta, Inc.
Novartis: Mayzent label update approved; four real-world studies registered or recruitingJul 2Weekly roundup, 7 itemsalpelisibFludarabine
Sign inSign in